| Lastest Insider Transactions Of Viridian Therapeutics, Inc.DE ( VRDN ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| VRDN | Viridian Therapeutics, Inc.DE | Fairmount Funds Management LLC | Directior 10% Owner | 2024-01-22 | Buy | 476,190 | 21.00 | 9,999,990 | 2024-01-24 18:44:41 |
| VRDN | Viridian Therapeutics, Inc.DE | Meisner Lara | Chief Legal Officer | 2023-06-15 | Sell | 2,296 | 28.02 | 64,343 | 2023-06-20 17:23:01 |
| VRDN | Viridian Therapeutics, Inc.DE | Meisner Lara | Chief Legal Officer | 2023-06-15 | Option Exercise | 2,296 | 23.03 | 52,877 | 2023-06-20 17:23:01 |
| VRDN | Viridian Therapeutics, Inc.DE | Meisner Lara | Chief Legal Officer | 2023-06-02 | Sell | 7,500 | 24.82 | 186,136 | 2023-06-06 19:41:29 |
| VRDN | Viridian Therapeutics, Inc.DE | Meisner Lara | Chief Legal Officer | 2023-06-02 | Option Exercise | 7,500 | 17.38 | 130,369 | 2023-06-06 19:41:29 |
| VRDN | Viridian Therapeutics, Inc.DE | Myers Scott Dunseth | Chief Executive Officer | 2023-04-12 | Buy | 4,000 | 25.37 | 101,479 | 2023-04-12 19:05:46 |
| VRDN | Viridian Therapeutics, Inc.DE | Myers Scott Dunseth | Chief Executive Officer | 2023-03-13 | Buy | 5,500 | 29.15 | 160,324 | 2023-03-13 16:06:51 |
| VRDN | Viridian Therapeutics, Inc.DE | Meisner Lara | General Counsel and Secretary | 2023-03-09 | Sell | 29,971 | 29.07 | 871,257 | 2023-03-10 16:05:12 |
| VRDN | Viridian Therapeutics, Inc.DE | Violin Jonathan | Chief Executive Officer | 2023-02-02 | Sell | 50,000 | 36.80 | 1,840,000 | 2023-02-07 18:35:01 |
| VRDN | Viridian Therapeutics, Inc.DE | Violin Jonathan | Chief Executive Officer | 2023-02-02 | Option Exercise | 50,000 | 0.15 | 7,500 | 2023-02-07 18:35:01 |
| VRDN | Viridian Therapeutics, Inc.DE | Violin Jonathan | Chief Executive Officer | 2023-02-02 | Sell | 50,000 | 36.80 | 1,840,000 | 2023-02-03 18:12:08 |
| VRDN | Viridian Therapeutics, Inc.DE | Meisner Lara | General Counsel and Secretary | 2023-01-23 | Sell | 6,843 | 35.66 | 244,021 | 2023-01-25 18:04:31 |
| VRDN | Viridian Therapeutics, Inc.DE | Meisner Lara | General Counsel and Secretary | 2023-01-23 | Option Exercise | 6,843 | 20.56 | 140,690 | 2023-01-25 18:04:31 |
| VRDN | Viridian Therapeutics, Inc.DE | Katz Barrett | Chief Medical Officer | 2023-01-13 | Sell | 29,000 | 37.18 | 1,078,261 | 2023-01-18 17:58:22 |
| VRDN | Viridian Therapeutics, Inc.DE | Katz Barrett | Chief Medical Officer | 2023-01-13 | Option Exercise | 29,000 | 23.03 | 667,870 | 2023-01-18 17:58:22 |
| VRDN | Viridian Therapeutics, Inc.DE | Katz Barrett | Chief Medical Officer | 2023-01-09 | Sell | 60,000 | 34.82 | 2,089,472 | 2023-01-11 19:09:33 |
| VRDN | Viridian Therapeutics, Inc.DE | Katz Barrett | Chief Medical Officer | 2023-01-09 | Option Exercise | 60,000 | 23.03 | 1,381,800 | 2023-01-11 19:09:33 |
| VRDN | Viridian Therapeutics, Inc.DE | Meisner Lara | General Counsel and Secretary | 2022-12-20 | Sell | 16,926 | 29.15 | 493,398 | 2022-12-22 16:42:42 |
| VRDN | Viridian Therapeutics, Inc.DE | Meisner Lara | General Counsel and Secretary | 2022-12-20 | Option Exercise | 16,926 | 23.03 | 389,806 | 2022-12-22 16:42:42 |
| VRDN | Viridian Therapeutics, Inc.DE | Meisner Lara | General Counsel and Secretary | 2022-12-15 | Sell | 1,597 | 28.37 | 45,311 | 2022-12-19 19:22:53 |
| VRDN | Viridian Therapeutics, Inc.DE | Meisner Lara | General Counsel and Secretary | 2022-12-15 | Option Exercise | 1,597 | 23.03 | 36,779 | 2022-12-19 19:22:53 |
| VRDN | Viridian Therapeutics, Inc.DE | Meisner Lara | General Counsel and Secretary | 2022-12-12 | Sell | 16,256 | 28.12 | 457,077 | 2022-12-14 20:56:50 |
| VRDN | Viridian Therapeutics, Inc.DE | Meisner Lara | General Counsel and Secretary | 2022-12-12 | Option Exercise | 16,256 | 23.03 | 374,376 | 2022-12-14 20:56:50 |
